Two hospitals use Varian RapidArc to treat brain metastases

Two cancer centers have carried out radiosurgery treatments for multiple brain metastases using new RapidArc radiotherapy technology from Varian Medical Systems.

The MIMA Cancer Center in Melbourne, Fla., and the VU University Medical Center in Amsterdam, Netherlands, have treated brain metastases with the technology, according to the Palo Alto, Calif.-based Varian.

RapidArc, which targets treatment beams at tumors while rotating continuously around the patient, makes it possible to complete stereotactic radiosurgery sessions faster than conventional techniques that use stationary beams, the company said.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.